In response to the recent “FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation…
nboutaouiMarch 13, 2020
Lyon, le 5 février 2020 - MaaT Pharma annonce aujourd'hui une levée de fonds de…
nboutaouiFebruary 4, 2020
Lyon, France, February 5, 2020 – MaaT Pharma announced today an €18 million Series B…
nboutaouiJanuary 31, 2020
Lyon, France, November 6, 2019 – MaaT Pharma announced today that a poster will…
nboutaouiNovember 6, 2019
Jean-Marc Renard, MS, MBA, joins as Chief Business Officer Emmanuel Prestat, PhD, joins as Computational…
nboutaouiSeptember 10, 2019
Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute…
nboutaouiJune 24, 2019